Abstract CT123: Trial in progress: First-in-human immunotherapy-trio for advanced head and neck squamous cell carcinomaMarcus Couey, Rom S. Leidner, Matthew Taylor et al.|Cancer Research|2023Cited by 0
680 Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinomaChristopher Paustian, Rom S. Leidner, Ryan Meng et al.|Regular and Young Investigator Award Abstracts|2023Cited by 0